Curbing Adverse Effects of CYP2D6 Substrates

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 112卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：933 / 933
页数：1
相关论文
共 50 条
  • [21] Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions
    LLerena, Adrian
    Dorado, Pedro
    Penas-LLedo, Eva M.
    PHARMACOGENOMICS, 2011, 12 (03) : 311 - 311
  • [22] CYP2D6 genotype and adverse events to risperidone in children and adolescents
    Oshikoya, Kazeem A.
    Neely, Katelyn M.
    Carroll, Robert J.
    Aka, Ida T.
    Maxwell-Horn, Angela C.
    Roden, Dan M.
    Van Driest, Sara L.
    PEDIATRIC RESEARCH, 2019, 85 (05) : 602 - 606
  • [23] Effects of the CYP2D6 genotypes on the pharmacokinetics of atomoxetine
    Choi, Chang-Ik
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    FASEB JOURNAL, 2011, 25
  • [24] The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity
    Dinh, Jean C.
    Boone, Erin C.
    Staggs, Vincent S.
    Pearce, Robin E.
    Wang, Wendy Y.
    Gaedigk, Roger
    Leeder, James Steven
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (03) : 646 - 654
  • [25] CYP2D6 polymorphism in a Gabonese population:: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype
    Panserat, S
    Sica, L
    Gérard, N
    Mathieu, H
    Jacqz-Aigrain, E
    Krishnamoorthy, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (01) : 121 - 124
  • [26] Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG Cells
    Li, Hongfang
    Tang, Yunyan
    Wang, Yang
    Wei, Weipeng
    Yin, Chengchen
    Tang, Fushang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5251 - 5258
  • [27] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
    Shiran, Mohammad R.
    Soteh, Mohammad B. Hashemi
    Merat, Fatemeh
    Sarzare, Fatemeh
    Salehifar, Ebrahim
    DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261
  • [28] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation:: a study of mutations CYP2D6*3 and CYP2D6*4
    Monek, O
    Paintaud, G
    Bechtel, Y
    Miguet, JP
    Mantion, G
    Bechtel, PR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (01) : 47 - 52
  • [29] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation: a study of mutations CYP2D6*3 and CYP2D6*4
    O. Monek
    G. Paintaud
    Y. Bechtel
    J. P. Miguet
    G. Mantion
    P. R. Bechtel
    European Journal of Clinical Pharmacology, 1998, 54 : 47 - 52
  • [30] CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene
    Skierka, Jennifer M.
    Walker, Denise L.
    Peterson, Sandra E.
    O'Kane, Dennis J.
    Black, John Logan, III
    PHARMACOGENOMICS, 2012, 13 (08) : 951 - 954
12345